Nuevos enfoques farmacológicos en el manejo de la angina de pecho estable

Franco, Juan-Sebastian; Calderón-Ospina, Carlos Alberto; López-Cabra, Claudia Alejandra.
Med. UIS ; 29(3): 79-93, sep.-dic. 2016. tab, graf
Artículo en Español | LILACS | ID: biblio-954891

Documentos relacionados

  1. Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes.
  2. Treatment of Angina: Where Are We?
  3. Association between Ranolazine, Ischemic Preconditioning, and Cardioprotection in Patients Undergoing Scheduled Percutaneous Coronary Intervention.
  4. Pharmacologic modulation of intracellular Na<sup>+</sup> concentration with ranolazine impacts inflammatory response in humans and mice.
  5. [Triple antianginal combinations in the treatment of elderly and senile patients with stable angina].
  6. Use of Ranolazine for the Treatment of Coronary Microvascular Dysfunction.
  7. Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.
  8. Ranolazine for stable angina pectoris.
  9. Delayed Ventricular Repolarization and Sodium Channel Current Modification in a Mouse Model of Rett Syndrome.
  10. Single dose oral ranolazine pharmacokinetics in patients receiving maintenance hemodialysis.